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A B S T R A C T
Preserved executive functioning (EF) is crucial for daily functioning in the elderly and it appears to predict
dementia development. We sought to clarify the role of atrophy-corrected cortical grey matter (GM) volume as a
potential brain reserve (BR) marker for EF in the elderly. In total, 206 pre-surgical subjects (72.50 ± 4.95 years;
mean MMSE score 28.50) were investigated. EF was primarily assessed using the Trail Making Test B (TMT B).
Global/ lobar GM volumes were acquired with T1 MP-RAGE. Adjusting for key covariates including a brain
atrophy index (i.e. brain parenchymal fraction), multiple linear regression analysis was used to study associa-
tions of GM volumes and TMT B. All GM volumes - most notably of global GM - were significantly associated
with TMT B independently of GM atrophy (ß =−0.201 to−0.275, p= 0.001–0.012). Using atrophy-corrected
GM volume as an estimate of maximal GM size in youth may serve as a BR predictor for cognitive decline in
future studies investigating BR in the elderly.
1. Introduction
The term cognitive reserve (CR) captures the fact that an individual
maintains the capability of performing cognitive tasks in the face of
neurological disease with a subsequent loss of neuronal function (Stern,
2012). The model of CR states that patients with higher intelligence
(IQ) or occupational attainment might have a functional advantage
during late life (Stern, 2002). Analogous to the concept of CR, brain
reserve (BR), in particular measures of brain structure, refers to the
hypothesis that the brain is capable of minimizing clinical manifesta-
tions in the face of age-related cerebral effects or the present neuro-
pathology (Bartrés-Faz and Arenaza-Urquijo, 2011; Chen et al., 2017).
Several studies reported that subjects with larger head circumference,
intracranial volume or brain weight with higher numbers of neurons
are less likely to develop dementia (Katzman et al., 1988; Mori et al.,
1997; Schofield et al., 1997). Furthermore, larger brain size may con-
stitute a possible morphological advantage with regard to overall cog-
nitive ability in the elderly (Pietschnig et al., 2015; Persson et al., 2016;
Feinkohl et al., 2017; Groot et al., 2017; Vibha et al., 2017).
In both, non-demented elderly subjects and patients with mild
cognitive impairment (MCI), a preserved superior level of executive
functioning (EF) is associated with superior daily functioning and aging
well (Schmitter-Edgecombe et al., 2011; Puente et al., 2015; Darby
et al., 2017). EF reflects a range of decision-making and higher-order
thinking processes like flexible problem-solving, working memory and
response inhibition (Stern, 2012; Puente et al., 2015; Darby et al.,
2017). In a recent long-term observation study, Chen et al. (2017) re-
ported that subjects with low baseline EF - but notably not with low
baseline memory performance - had a higher conversion rate from
normal cognition to MCI. Similar observations were made by others
(Royall et al., 2004; Johnson et al., 2007). Johnson et al. (2007) un-
dertook a prospective study of 7717 elderly women (mean modified
MMSE of 24.8 points), and observed that impaired EF at baseline,
measured by the Trail Making Test (TMT) B, rather than global cog-
nitive function was associated with significantly worse daily func-
tioning both in a cross-section manner and over six years. In a three-
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year longitudinal cohort study of 547 non-demented elderly, Royall
et al. (2004) showed that EF instead of e.g. the MMSE score was the
most accurate predictor of functional status over time. Comparable
results were reported by Rozzini et al. (2007), who observed an asso-
ciation of conversion to Alzheimer's disease (AD) with poor global
cognitive performance at baseline and with worsening executive func-
tioning, but not with worsening memory performance (one year follow-
up period) in a group of amnestic MCI individuals. These findings
suggest that EF is a particularly relevant constituent of CR.
Phillips et al. (2008) demonstrated that cognition and behavior in
older non-demented adults are highly dependent on EF, which, in turn,
is associated with prefrontal brain function. Multiple studies of elderly
subjects have demonstrated that the integrity of the different brain
lobes, most notably the frontal lobe, are associated with EF (Elderkin-
Thompson et al., 2008; Cardenas et al., 2011; Zhang et al., 2011; Dong
et al., 2015). More recently, however, Bettcher et al. (2016) reported
findings that are not easily reconciled with the hypothesis of an out-
standing role of the frontal lobe with respect to EF in the aging process.
In their study (N=202), cortical grey matter (GM) volume of the
frontal lobe as well as additional brain lobes were not independently
associated with EF performance when statistically corrected for global
GM volume. Importantly, all of these studies have in common that they
quantify GM volume without distinguishing whether it is the maximal
brain size in youth or GM atrophy during later life that predicts EF in
elderly subjects. Accordingly, any association between frontal or global
GM volume and EF can be interpreted in two different ways. Low EF
performance can result from age-associated cortical atrophy, small GM
volumes already at a young age (BR) or both. The concept of brain
reserve (BR) is mostly attributed to passive individual differences of
morphological brain characteristics enduring neuropathological pro-
cesses (Bartrés-Faz and Arenaza-Urquijo, 2011). Reaching a critical
threshold of brain damage might result in clinical and functional defi-
cits becoming apparent (Satz et al., 1993). A number of studies have
found impaired EF preceding memory decline in the course of dementia
development (Johnson et al., 2007) and the literature has pointed out
the need to consider brain morphology associated with EF possibly
serving as an early marker of neurodegenerative disease (Chen et al.,
2017). Thus, as brain atrophy is suggested to be an early risk indicator,
brain imaging might be beneficial by delivering diagnostic and prog-
nostic information to patients in the process of individual personalized
medicine (Chen et al., 2017).
In the present study, we sought to clarify, whether maximal GM
volume in youth, i.e. the cortical BR, contributes to EF in the elderly. In
addition, we addressed the question of whether frontal or global GM
volume is associated with EF. For the neuropsychological assessment of
EF the commonly used trail-making tests were applied (Reitan, 2004;
Rabin et al., 2005) which have been hypothesized to reflect a wide
variety of cognitive processes such as visual searching and scanning,
flexibility and the ability to execute and modify a plan of action
(Salthouse, 2011). In order to estimate cortical GM during youth as a
BR marker in our elderly patient group, we adopted a novel strategy
which - to the best of our knowledge - has not been previously applied.
We calculated a brain atrophy index (brain parenchymal fraction, BPF),
i.e. the ratio of the total brain parenchymal volume (BPV), which in-
cludes GM and white matter (WM), to the total intracranial volume
(ICV). In the past, BPF has been used as a measure of brain atrophy, for
instance by the Alzheimer's Disease Neuroimaging Initiative con-
sortium, to predict cognitive decline in dementia patients (Callahan
et al., 2015). Literature concerning the application of BPF in healthy
individuals is sparse; in particular, evaluation of the course of brain
atrophy in healthy adults. Vågberg et al. (2017) investigated cross-
sectional data of BPF that are currently available in the literature and
highlighted in a systematic review that the BPF values in healthy in-
dividuals increase until the age of 40, whereas a progressive rate of
atrophy occurs along with further aging. Since ICV is stable throughout
adulthood, it represents an "archeological" estimate of maximal brain
size in youth (Royle et al., 2013). Thus, we used BPF in our study to
correct an individual GM volume for GM atrophy, which lends this
measure to the quality of a BR prediction marker even when imaging
data are collected at advanced age in a cross-sectional study design.
Accordingly, this strategy of data analysis extends recent work using
ICV per se as a BR marker for the prediction of dementia development
(Guo et al., 2013; Negash et al., 2013; Groot et al., 2017). The rationale
of our approach is the well-known inter-individual variability (~ 10%)
of the ratio between ICV and cortical GM volume (Ge et al., 2002).
2. Material and methods
2.1. Participants
In total, 206 neuropsychologically healthy adults (aged: 65–87
years), were selected as part of an interim analysis from a cohort study
within the framework of the Biomarker Development for Postoperative
Cognitive Impairment in the Elderly (BioCog) study (www.biocog.eu).
The BioCog study is a prospective 2-center (Charité University Hospital
Berlin (Germany) and the University Hospital Utrecht (Netherlands))
observational cohort study with N=1033 elderly elective surgical
patients, aiming to establish valid clinical, neuroimaging and molecular
biomarker panels for risk and clinical outcome prediction of post-
operative delirium and postoperative cognitive deficits (Winterer et al.,
2018). According to the study protocol, pre-operative data of the first
400 enrolled patients can be used for interim analyses (data from
N=291 patients in the Charité University Hospital Berlin (Germany)
and N=109 patients from the University Hospital Utrecht (Nether-
lands)). In the present study, only data from patients from the clinical
center of Berlin, who were recruited in the entire area of the city of
Berlin, were used for analyses. Since approximately 50% of all surgical
interventions in the Berlin area, with roughly five million inhabitants,
are conducted at the Charité University Hospital, the study cohort in
Berlin ensures a good coverage of elderly surgical patients in the region
(Winterer et al., 2018). The inclusion criteria comprise male and female
patients aged≥ 65 years and of European descent (Caucasian) who are
scheduled for elective surgery. Study participants with ≤ 23 points in
the Mini-Mental-State-Examination (MMSE), a life-time history of
neuropsychiatric disorders or addiction disorders during the past five
years or with centrally acting medication were excluded (complete list
of eligibility criteria: https://clinicaltrials.gov/ct2/show/
NCT02265263?term=biocog&rank=1). The study is registered at
ClinicalTrials.gov: NCT02832193. All patients have given written in-
formed consent after receiving spoken and written information on the
study. The study was approved by the local ethics committee and
conducted according to the declaration of Helsinki.
Magnetic resonance imaging (MRI) data acquisition together with
clinical and neurocognitive assessments took place one day before
surgery. In total, 218 MRI scans were available for this interim analysis
using data from the patients from the clinical center of Berlin
(N= 291). Due to the withdrawal of consent by one patient after in-
clusion and one case with preterm finishing of the FreeSurfer processing
pipeline, as well as ten cases with gross anatomical aberrations seen
while inspecting the post-processed images, 206 processed MRI scans
were finally available for analysis. Of the 206 available MRI scans, TMT
B data were available for 174 subjects (for demographics see Table 1).
2.2. Measures
2.2.1. Cognitive assessments
For the assessment of executive functioning, the Trail Making Test
(TMT A and TMT B) was applied on the same day as the MRI in-
vestigation. The measurement of visuoperceptual abilities, which are
speeded (motor) measures, is mainly reflected by part A of the TMT,
whereas inhibition and set-shifting ability is reflected by part B
(Arbuthnott and Frank, 2000; Strauss et al., 2006; Sánchez-Cubillo
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et al., 2009). By calculating a difference score (TMTDiff= TMT B – TMT
A) the variance attributable to the graphomotor and visual scanning
components of the TMT A are minimized (Sánchez-Cubillo et al., 2009;
Misdraji and Gass, 2010). While comparing the TMTDiff score to other
neuropsychological measures, correlations to memory functioning were
found (Corrigan and Hinkeldey, 1987; Sánchez-Cubillo et al., 2009).
However, statistically significant effects are inconsistent and more re-
cent investigations showed that the TMT B score might be more
strongly associated with working memory than the TMTDIFF score
(Sánchez-Cubillo et al., 2009; Fellows et al., 2017). During part A,
subjects are required to connect numbers on a sheet of paper in the
correct order as quickly as possible. During part B subjects have to draw
lines on a sheet of paper sequentially connecting 25 encircled numbers
and alternating letters (1, A, 2, B, 3, C, etc.). In the present study, the
required time to finish the TMT B is used as the primary dependent
variable. Due to the dependence on intelligence, visuomotor co-
ordination and age, literature regarding standard cut-off values for the
TMT is sparse (Spreen and Strauss, 1998; Tombaugh, 2004). For re-
ference norm values across age groups, see Tombaugh (2004). For the
assessment of the Intelligence Quotient (IQ) score, the multiple choice
vocabulary test ("Mehrfachwahl-Wortschatz-Intelligenztest" (MWT-A))
was applied to assess crystallized cognitive ability (Lehrl, 2005). The
derived IQ score correlates fairly well with global IQ in healthy adults
(Lehrl et al., 1995).
2.2.2. Education
According to the International Standard Classification of
Educational Degrees (ISCED-1997) (approved by the United Nations
Educational Scientific and Cultural Organization (UNESCO) General
Conference at its 29th session in November 1997) and following pre-
vious procedures (Kave et al., 2012), the educational level of the sub-
jects was classified into one of seven categories: (0) preprimary edu-
cation, (1) primary education, (2) lower secondary education, (3) upper
secondary education, (4) post-secondary education, (5) first tertiary
education and (6) second stage tertiary education. The ISCED 1997
levels of 2 and 3 are sub-classified into a,b,c and levels 4 and 5 in a,b
depending on the educational level attained. The ISCED score was in-
itially developed by the UNESO in the early 1970s as a framework to
collect, illustrate and compare educational statistics on a national as
well as international level.
2.2.3. Structural neuroimaging
MRI scans were obtained on a 3.0 T MRI scanner (Siemens
Magnetom Trio) using a 32-channel head coil. Structural imaging yields
whole head high-resolution anatomical magnetic resonance images
using a 3D T1-weighted magnetization-prepared rapid gradient-echo
sequence (MP-RAGE) for studying cortical volume. An axial-oblique 3D
Fast Spoiled Gradient Recalled Echo (FSPGR) sequence for the T1-
weighted sequence was applied (TR/TE=2500/4.77ms, α=7°). A
field of view of 256× 256mm, with 1×1mm in-plane resolution and
1mm slice thickness was applied. After acquisition, all MRI images
were checked on pathological intracranial processes by a board-certi-
fied neuroradiologist.
2.2.3.1. FreeSurfer. The FreeSurfer software package was used in order
to allow a direct comparison with earlier studies. Furthermore in order
to process T1 MP-RAGE structural MR images, the software FreeSurfer
(version 5.30) was used due to its fully automated pipeline and its free
availability (http://surfer.nmr.mgh.harvard.edu), as well as a good
test-retest reliability (Han et al., 2006; Jovicich et al., 2006). The
steps executed were motion correction, the removal of non-brain tissue
and automated Talairach transformation (Segonne et al., 2007). The
pipeline of FreeSurfer conducts segmentation of the subcortical white
matter and deep grey matter into structural volumes (Fischl et al.,
2002), intensity normalization (Sled et al., 1998), tessellation of the
grey matter into structural volumes (Fischl et al., 2002, 2004),
automated topology correction (Fischl et al., 2002) and surface
deformation (Dale et al., 1999; Fischl and Dale, 2000). All surfaces of
each individual image data were visually inspected post-processing for
the accuracy of spatial registration and grey/white matter segmentation
(e.g. removal of skull and dura mater and accurate delineation of grey/
white matter and pial surfaces). Since all subjects were manually
checked by one researcher (M.L.), potentially differing inter-observer
interpretations of the accuracy of processed images were avoided.
FreeSurfer provides a 3-dimensional segmentation method in order to
allocate each voxel to a neuroanatomical label. The global GM volume
was calculated by summing up specific GM volumes which were
segmented into 68 parcellations using the Desikan-Killiany atlas
(Desikan et al., 2006). The individual parcellations were summed up
to estimate the frontal, temporal, occipital and parietal lobe GM
volumes (Fischl et al., 2004; Desikan et al., 2006). Since the primary
motor and the sensory cortex are mainly involved in controlling motor
action, respectively receiving input from peripheral mechanoreceptors
(Lotze et al., 1999) by excluding the associated cortical volumes from
global GM as well as specific lobar volumes, we sought to eradicate the
bias of reduced dexterity and somatosensory inaccuracy with respect to
the conducted tests. The same approach of excluding the primary motor
and the sensory cortex from the calculations of the volumes of the
frontal, respectively the parietal lobe, was chosen by Bettcher et al.
(2016).
2.2.3.2. Brain parenchymal fraction. Correction for global cerebral
atrophy was executed by first calculating the estimated total
intracranial volume (eTIV, aka ICV) as well as the total brain
parenchymal volume (global GM volume plus total WM volume
Table 1
Cognitive and neuroimaging characteristics of participants.
N Mean (SD) Range
Demographics
Age (years) 206 72.50 (4.95) 65–87
Male Sex (%) 118 57.28
Education
ISCED 1997 Level 183 2 A/B: 23.00%
3A/B/C: 38.20%
4A/B: 3.20%
5A/B: 35.60%
Education (years) 166 13.02 (4.15) 6–24
Executive Functions Measures
TMT A (sec) 189 50.30 (19.21) 19–132
TMT B (sec) 174 119.56 (51.01) 25–298
Intelligence Test
IQ score 121 114.07 (14.14) 70–143
MMSE 206 28.50 (1.41) 24–30
Neuroimaging Measures
Total intracranial volume (mm3) 206 1.338.010
(203.127)
922.433–2.007.198
Total brain parenchymal volume
(mm3)
206 979.727
(101.958)
705.772–1.222.338
Total cortical GM volume
(mm3)a,b
206 310.639 (30.572) 233.497–394.180
Frontal lobe GM volume (mm3)a 206 123.858 (12.543) 93.016–164.200
Parietal lobe GM volume (mm3)b 206 85.802 (8.888) 66.548–111.093
Temporal lobe GM volume
(mm3)
206 61.794 (6.779) 45.140–80.615
Occipital lobe GM volume
(mm3)
206 39.185 (4.760) 28.485–52.202
BPF (BPV/ICV) 206 0.742 (0.088) 0.53–0.99
GMF (GMV/ICV) 206 0.235 (0.028) 0.16–0.30
Key: BPF, Brain Parenchymal Fraction; BPV, Brain Parenchymal Volume; GM,
Grey Matter; GMF, Grey Matter Fraction; GMV, Grey Matter Volume; ICV,
Intracranial Volume; IQ, Intelligence Quotient; ISCED, International Standard
Classification of Education; mm, millimeters; MMSE, Mini-Mental State
Examination; SD, standard deviation; sec, seconds; TMT, Trail Making Test.
a Excluding primary motor cortex.
b Excluding sensory cortex.
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excluding ventricles). The software FreeSurfer calculates the total
intracranial volume by exploiting the relationship between the ICV
and the linear transform to MNI305 space and using an atlas-based
spatial normalization procedure (Buckner et al., 2004). The cerebral
atrophy index, i.e. the brain parenchymal fraction (BPF), was
subsequently derived by dividing the total brain parenchymal volume
(BPV) by the total intracranial volume (ICV) (Rudick et al., 1999;
Callahan et al., 2015).
2.3. Statistical analysis
For statistical analyses, SPSS (version 25) was used. In total, three
sets of analyses were executed. 1) Five separate linear multiple re-
gression analyses for each of the four brain lobes (GM volume) and the
global GM volume were executed, each time including age, the BPF and
sex as additional independent variables and the TMT B score as the
dependent variable (analogous calculation with the dependent variable
TMTDiff score). 2) In order to adjust for global GM volume, the GM
volume of each of the four different lobes was divided by the global GM
volume and the regression analyses with TMT B scores were repeated in
the same way. Additionally, multiple regression analyses for the IQ
score and the educational level as dependent variables and global GM
volume, age, BPF and sex as the independent variables were conducted.
Following a recent suggestion by Van Loenhoud et al. (2017), we fur-
thermore repeated our calculations replacing the atrophy index BPF by
GMF (Grey Matter Fraction) (GM/ICV). 3) Via linear regression ana-
lyses, we tested sex-specific effects on the correlation of age with the
TMT B performance for small and large global GM volumes. The critical
value for significance was set to p < 0.05.
3. Results
The 206 non-demented elderly Caucasian surgical patients in-
vestigated had a mean MMSE score of 28.50 points (range 24–30, SD
1.41) and a mean educational attainment of 13 years of education
(range 6–24, SD 4.12). The effects of the different GM volumes of the
four lobes and the global GM volume on the TMT B score are shown in
Table 2.
All volumes of the different lobes and the global GM volume were
negatively associated with the TMT B scores (see also Fig. 1).
The model shows that every increase of one standard deviation (SD)
of each individual GM volume, as well as the global GM volume, sig-
nificantly lowers the TMT B score. In other words, faster TMT B per-
formance is associated with larger individual and larger global GM
volumes. In detail, an increase of one SD of the frontal GM volume
decreases the TMT B score by 0.229 SDs (p=0.006), the increase of
one SD of the parietal GM volume decreases the TMT B score by 0.263
SDs (p=0.002), the increase of one SD of the temporal GM volume
decreases the TMT B score by 0.263 SDs (p=0.002) and an increase of
one SD of the occipital GM volume decreases the TMT B score by 0.201
SDs (p=0.012); also, an increase of one SD of the global GM volume
decreases the TMT B score by 0.275 SDs (p= 0.001). The standardized
coefficient (-ß-) of the global GM volume of −0.275 (p= 0.001) is
most negatively related to the TMT B score in our model and, thus, is
the most accurate predictor of all region-of-interests (GM volumes). Age
also has significant explanatory power to predict TMT B performance;
higher age is associated with a higher TMT B score (ß=0.187–0.209,
p=0.007–0.015). No sex-specific tendencies were observed
(ß=−0.085 to−0.139, p= 0.096–0.326). Similar results were found
when including the primary motor and the sensory cortex in the cal-
culations of the frontal, respectively the parietal lobe as well as the
global GM volume (see Table 1 in the Supplement). Furthermore, we
found that the TMT B - TMT A score was also accurately predicted by
the global GM volume (ß=−0.269, p= 0.002), although the asso-
ciation of the temporal GM volume with the TMTDIFF score was slightly
more pronounced (ß=−0.284, p=0.001) (see Table 2 in the
Supplement).
The BPF itself, except for the regression analysis including the
parietal lobe (p=0.045), did not contribute significantly to the pre-
diction of EF measured by the TMT B (p=0.056–0.121); however, non-
significant trends were observed (see Tables 2 and 3). Of note, Fig. 2
shows only slight variance in brain atrophy across the MMSE scores
(24–30 points).
As shown in Table 3, when running the multiple regression in-
cluding the ratio consisting of the lobar GM volumes divided by the
global GM volume, no associations of different lobar GM ratios ("ad-
justed lobar GM volumes") with the TMT B score were found. In this
model, consisting of the "adjusted lobar GM volumes", age, BPF and sex
as independent variables and the TMT B score as the dependent vari-
able, the lobar GM ratios did not significantly predict performance at
the TMT B (beta= −0.019 to 0.062, p=0.388–0.789). In this model,
consisting of adjusted GM volumes (see Table 3), male sex was statis-
tically significantly negatively associated with the prediction of per-
formance in the TMT B (ß-values: −0.222 to −0.230,
p=0.003–0.004). Higher age was observed to significantly predict the
TMT B score positively (ß-values: 0.231–0.237, all p= 0.002–0.003).
Replacing the atrophy index BPF by GMF did not markedly change
the obtained results (see Table 3 in the Supplement).
As part of a moderation analysis, the moderator effect of small and
large global GM volume on the relation between age and the TMT B
score was investigated (Fig. 3). We observed that the strength re-
lationship of age and TMT B changes as a function of global GM volume.
In the subgroup of larger global GM volume of male participants, the
correlation between age and TMT B was weaker (R2 =0.106) com-
pared to the smaller global GM volume (R2 =0.154). For female
Table 2
Associations of individual lobar and global GM volume, age, the BPF and sex
with the score of the TMT B.
Independent
Variable
Dependent
variable
Estimate Standard
error
p-value
Frontal GM volume
(mm³)a
TMT B -0.229 <0.001 0.006
Age (years) 0.191 0.804 0.014
BPF (BPV/ICV) -0.151 45.641 0.056
Sex (female) -0.120 8.669 0.154
Parietal GM volume
(mm³)b
TMT B -0.263 <0.001 0.002
Age (years) 0.199 0.792 0.009
BPF (BPV/ICV) -0.158 45.340 0.045
Sex (female) -0.098 8.705 0.245
Temporal GM volume
(mm³)
TMT B -0.263 0.001 0.002
Age (years) 0.190 0.797 0.013
BPF (BPV/ICV) -0.146 45.368 0.065
Sex (female) -0.095 8.805 0.270
Occipital GM volume
(mm³)
TMT B -0.201 0.001 0.012
Age (years) 0.209 0.799 0.007
BPF (BPV/ICV) -0.124 46.220 0.121
Sex (female) -0.139 8.551 0.096
Global GM volume
(mm³)a,b
TMT B -0.275 <0.001 0.001
Age (years) 0.187 0.796 0.015
BPF (BPV/ICV) -0.146 45.261 0.063
Sex (female) -0.085 8.861 0.326
The model consists of the different grey matter volumes, age, the BPF and sex
entered as independent variables and the TMT B score (sec) as a dependent
variable. Estimates are standardized regression coefficients of this model. The
reference of the standardized regression coefficient of sex is female.
Key: BPF, Brain Parenchymal Fraction; BPV, Brain Parenchymal Volume; GM,
Grey Matter; ICV, Intracranial Volume; mm, millimeters; sec, seconds; TMT,
Trail Making Test
a excluding primary motor cortex
b excluding sensory cortex
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participants, however, these observations were not consistent and could
not be demonstrated (see Fig. 3). For female participants, we found that
the correlation of age and TMT B was weaker in the subgroup of smaller
GM volume (R2 =0.001) compared to the subgroup of larger global
GM volume (R2 = 0.126).
Moderate negative correlations (all p values< 0.01, two-tailed)
were observed for the TMT B with the IQ score (r=−0.397), and for
the TMT B score with completed years of education (r=−0.354)
whereas the IQ score was moderately positively correlated with com-
pleted years of education (r= 0.388). Additionally, we regressed the IQ
score as well the educational attainment, reflected by the ISCED
(International Standard Classification of Education) 97 Level, on global
Fig. 1. Each scatterplot consists of the graph of the standardized predicted values derived from the regression equation composed of the individual GM volumes
(excluding primary motor and sensory cortex) as well as the covariates age, BPF and sex (95% CI). Key: BPF, Brain Parenchymal Fraction; CI, Confidence Interval;
GM, Grey Matter; sec, seconds; TMT B, Trail Making Test.
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GM volume as well as the covariates of age, the BPF and sex. Thereby,
we observed that global GM volume could neither significantly predict
the IQ score (beta=0.179; p=0.088) nor the ISCED 97 Level
(beta=0.093; p=0.245).
4. Discussion
In this study, the associations of different lobar GM volumes and
global GM volume with EF as well as the approach of using an atrophy-
corrected global GM volume as a BR prediction marker were examined.
We observed that global GM volume was most strongly associated with
EF, i.e. patients with a larger GM volume demonstrated superior TMT B
performance. The second strongest associations were observed for the
parietal and temporal lobe followed by the frontal lobe, whereas the
occipital lobe was the least correlated with EF. Since we corrected GM
volume for brain atrophy as part of the multiple regression analyses,
our measures of "corrected GM volume" can be considered an "arche-
ological" estimate of the maximal brain size in youth (Royle et al.,
2013). The neuropsychological and neuroimaging tests were conducted
on the same day; thus, confounding factors such as day-to-day phy-
siological variations of brain volumes (Duning et al., 2005) were
minimized. We corrected the global GM volume for cerebral atrophy;
accordingly, despite adopting a cross-sectional study design, the latter
is applicable as a predictor of EF even in advanced aged subjects. Global
GM volume also was a relevant predictor of TMTDiff score, but we ob-
served a stronger relationship for the temporal GM volume. Associa-
tions of the TMTDIFF score with memory functioning are described in
literature (Corrigan and Hinkeldey, 1987; Sánchez-Cubillo et al., 2009);
thus, our observations are in line with several prior studies which
showed that the temporal GM volume was most accurately related to
working memory (Bailey et al., 2013; Bettcher et al., 2016). However,
there is also literature indicating that the TMT B – TMT A score might
rather be a relatively pure indicator of EF (Sánchez-Cubillo et al.,
2009); further studies are needed to evaluate the significance and dis-
tinct interpretations for the TMTDIFF score. Notably, our observations
point in the same direction as previous studies showing a morphological
advantage, e.g. larger ICV protects against dementia development (Guo
et al., 2013; Negash et al., 2013; Groot et al., 2017). In any case, since it
is suggested that CR and BR have independent and synergistic con-
tributions to compensate for brain pathology (Stern, 2012) which may
reciprocally influence each other (Persson et al., 2016) global GM vo-
lume at least appears to be a reasonable quantitative reserve marker in
the elderly. In this way, both global GM volume and the associated EF
can be used as reserve markers for the prediction of transition to MCI
(Chen et al., 2017), transition of MCI to Alzheimer's disease (Albert
et al., 2001) or to address the question of whether the clinical mani-
festation of existing Alzheimer pathology is concealed (Darby et al.,
2017), which in turn may help to disentangle the heterogeneity of brain
aging, including age-related changes to brain function (Burzynska et al.,
2012).
In order to correct for possible age-related brain atrophy, we used
the BPF as an independent variable in our regression analyses. Synek
and Reuben (1976) first proposed the correlation of the ventricular to
brain area (VBR) as an index based on a structure's area, whereas the
introduction of the ratio BPV to ICV (BPF) is first referred to Rudick
et al. (1999). By applying FreeSurfer, the reliability of measures is
improved and the particular structure as well as the cerebral size is less
subject to error compared to measurement results from earlier decades.
Due to the improved reliability and reproducibility, we expected to
introduce a lower error, consequently achieving a higher reliability of
the BPF. In our study, the BPF did not, except for the parietal lobe, show
a statistically significant effect on EF – although this was a non-sig-
nificant trend. This is likely due to the sample composition in our study
with clearly non-demented patients and only a slight variance of the
MMSE score (see Fig. 2), as reflected by a median score of> 28.
As part of the moderation analyses, we showed a sex-specific buffer
effect of global GM volume on the TMT B performance in the elderly
(see Fig. 3). For male participants a positive influence of larger global
GM volume, by means of a "buffering" effect, on the correlation between
age and TMT B was observed. For female participants, however, con-
trasting observations were made. The subgroups were rather small
(female= 73, male= 101), with a fairly large distribution of data va-
lues; therefore, interpretation of the prior moderation analyses are
limited. However, it is conceivable that in a larger cohort, there might
be a stronger, sex-independent effect of brain size, i.e. an age de-
pendency of smaller GM volume being associated with worse EF. In
Table 3
Associations of specific adjusted lobar volumes, age, the BPF and sex with ex-
ecutive functioning measured by the TMT B.
Independent Variable Dependent
variable
Estimate Standard
error
p-value
Adjusted frontal GM
volume (frontal
GMa/global GMa,b)
TMT B 0.062 342.909 0.388
Age (years) 0.237 0.809 0.002
BPF (BPV/ICV) -0.146 46.664 0.071
Sex (female) -0.222 7.892 0.004
Adjusted parietal GM
volume (parietal
GMb/global GMa,b)
TMT B -0.029 399.303 0.689
Age (years) 0.234 0.811 0.003
BPF (BPV/ICV) -0.155 47.019 0.059
Sex (female) -0.230 7.845 0.003
Adjusted temporal GM
volume (temporal
GM/global GMa,b)
TMT B -0.026 423.045 0.717
Age (years) 0.231 0.808 0.003
BPF (BPV/ICV) -0.150 46.675 0.064
Sex (female) -0.227 7.885 0.003
Adjusted occipital GM
volume (occipital
GM/global GMa,b)
TMT B -0.019 410.687 0.789
Age (years) 0.232 0.808 0.003
BPF (BPV/ICV) -0.147 47.449 0.075
Sex (female) -0.229 7.857 0.003
The model consists of the adjusted specific grey matter volumes, age, the BPF
and sex entered as independent variables and the TMT B score (sec) as de-
pendent variable. Estimates are standardized regression coefficients of this
model. The reference of the standardized regression coefficient of sex is female.
Key: BPF, Brain Parenchymal Fraction; BPV, Brain Parenchymal Volume; GM,
Grey Matter; ICV, Intracranial Volume; mm, millimeters; sec, seconds; TMT,
Trail Making Test
a excluding primary motor cortex
b excluding sensory cortex
Fig. 2. The scatter plot consists of the brain parenchymal fraction (BPF) shown
on the y-axis which is derived by dividing the total brain parenchymal volume
(BPV) by the total intracranial volume (ICV). The MMSE score is shown on the
x-axis (95% CI). Key: CI, Confidence Interval; MMSE, Mini-Mental-State-
Examination.
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other words, the negative influence of age on EF might be moderated by
global GM volume.
The observed associations of different brain volumes with EF are in
line with reports from earlier studies. Elderkin-Thompson et al. (2008)
manually masked the prefrontal cortex of MRIs of 23 healthy elderly
individuals which were subsequently segmented automatically; dif-
ferent regions of the prefrontal GM volume were computed as ratios of
intracranial volume. They found that specific prefrontal sub-regions are
correlated with EF (Elderkin-Thompson et al., 2008). Using an ex-
plorative voxel-based morphometry approach, Zhang et al. (2011) re-
ported associations of EF with four different brain lobes (frontal, tem-
poral, parietal, and occipital) in 326 subjects. By applying deformation-
based morphometry (DBM), Cardenas et al. (2011) showed that im-
paired EF is associated with smaller frontal lobe volumes (N=71). The
limitations of these three studies are mainly due to the applied image
processing approaches that are accompanied by a compelling inter-
observer variance. By applying the FreeSurfer software package, Dong
et al. (2015) overcame these limitations and observed associations be-
tween GM volumes and cognitive performance in a large sample
(N=813) from the Northern Manhattan Study (NOMAS). Superior EF
performance was primarily associated with greater frontal lobe volume
(Dong et al., 2015). However, patients of different ethnicities with
neurocognitive disorders such as dementia were not excluded, which
impedes a direct comparison with our findings. In contrast, in the study
of Bettcher et al. (2016), a sub-cohort of the NIH Aging and Cognition
study (neurologically healthy older adults of undisclosed ethnicity),
participants with neurocognitive disorders were not included and
FreeSurfer was used for processing of the MR images with little inter-
observer variance. In line with our findings, they found associations
between EF performance and global as well as lobar structures,
including frontal GM volumes. Accordingly, the study of Bettcher et al.
(2016) and our study suggest that an isolated view on particular cor-
tical volumes may not be sufficient to fully grasp association with EF in
elderly non-demented subjects – in fact, our study results suggest that
global GM volume is the best predictor. Most importantly, none of these
studies specifically addressed BR; rather, the focus was on brain
atrophy.
It is important to acknowledge that brain atrophy trajectories might
be non-linear across different brain tissues, e.g. there is evidence that
WM volume decline is significantly greater than GM volume decline in
old age, particularly in the 9th decade (Royle et al., 2013). Since this is
not entirely elucidated, in the future long-term data on changes in the
grey/white matter ratio are needed to account for any divergence of
trajectories; subsequently, the influence on the strategy to apply GM
volume as a BR marker using BPF for brain atrophy correction will need
to be carefully evaluated. From longitudinal measures acquired
throughout the life span, it is known that regional brain volume does
change in healthy adults (Raz et al., 2005). Neuroimaging in vivo data
could demonstrate that there are global and spatially-localized re-
lationships of normal ageing and brain morphology (Sowell et al., 2003;
Fjell et al., 2013). Ubiquitous longitudinal cortical grey matter volume
losses were observed in multiple studies (Scahill et al., 2003; Sowell
et al., 2003), in particular in the prefrontal (Pfefferbaum et al., 1998;
Resnick et al., 2003; Sowell et al., 2003) and parietal regions (Sowell
et al., 2003). Fjell et al. (2013) found an accelerated decline for total
brain volume at the end of the 20 s as well as from the age of 60 on-
wards. Pfefferbaum et al. (2013) described a cubic function for frontal
lobe volume changes longitudinally, likewise indicating two points of
accelerated decline - the first occurring in the late 20 s and the second
after 60 years of age. One explanation might be that regions which
Fig. 3. To assess the effects of GM volume on the TMT B score, we assigned the subjects into four groups. This was done by a median split of the global GM volume
(primary motor and sensory cortex are excluded) for the female and the male subjects separately. On the top of this figure, displayed for female participants (N=73),
the TMT B is regressed onto age and shown as dichotomized into small global GM volume (N=33) on the left and into large global GM volume on the right side
(N=40). The lower part of this figure shows the regression of the TMT B onto age for male participants (N= 101). Displayed in the lower part, for male participants,
is the global GM volume split into small (N=51) on the left and large (N=50) on the right side (95% CI). Key: CI, Confidence Interval; GM, Grey Matter; sec,
seconds; TMT B, Trail Making Test B.
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mature late contain more thin myelinated fibers and are consequently
more vulnerable to age-related decline in terms of primary degenerative
events in the early period of the 20s (Raz et al., 2000; Bartzokis, 2004).
Furthermore, late critical ages accompanied by the demyelination of
larger connections occurring in the late 60 s (Fjell et al., 2013). Hip-
pocampal shrinkage was found to be substantial and accelerate with
age (Scahill et al., 2003; Raz et al., 2005) following a slight increase in
volume until the age of 50 (Pfefferbaum et al., 2013). Furthermore, the
choice of post-processing method for brain volume quantification of
longitudinal as well as cross-sectional data also impairs the opportunity
for the direct comparability of data in general and in particular of the
BPF (Vågberg et al., 2017), as well the ICV estimation (Nordenskjold
et al., 2013). Also, the dehydration-rehydration status of each patient
has a physiological effect on brain volume (Duning et al., 2005);
thereby complicating the quantification of longitudinal change (Scahill
et al., 2003). In the present study, the BPF index was applied to cal-
culate the potential BR marker of atrophy-corrected grey matter vo-
lume. Since the literature indicates that the BPF varies throughout the
individual's lifetime (Vågberg et al., 2017), further studies with mul-
tiple measurement time points investigating individual healthy subjects
longitudinally, aiming to establish normative age-related values, are
needed. As a further limitation to interpretation, it is prudent to high-
light that TMT was the sole indicator of executive functions applied.
Next to extensive neuroimaging assessments, additionally to the mea-
sured EF we also conducted many neuropsychological tests of other
cognitive functions; thus, adding further EF domains could have led to
higher dropout rates, and the tests might be ecologically less valid in an
unfamiliar environment such as the laboratory (Luis et al., 2003).
However, covering more extensive executive processing data is im-
portant to evaluate various EF domains and might therefore reduce
bias. Future studies may want to include a more detailed character-
ization of executive functions (e.g. the Miyake's conceptual framework
for executive functions (Miyake et al., 2000)) to validate the role of
atrophy-corrected grey matter volume as potential reserve marker for
EF in late life. For all of the conducted multiple regression analyses,
rather small adjusted R-squared values were observed, ranging from
0.157 (occipital lobe) to 0.181 (parietal lobe and global GM volume).
Thus, an essential part of residual variation between individuals in EF
cannot be referred to cortical GM volume (corrected for key predictors)
and the latter might have been operationalized in a rather simplified
manner. This is in line with prior large-scale investigations observing
that only 33% of the variance in cognition is explained by brain volu-
metrics (adjusted for ethnicity, age, education, and sex) (Gupta et al.,
2015). Further investigations are needed to address the large gap in the
knowledge regarding variables to explain the variation in cognition. To
fulfill the need for an explanation of variations in cognitive perfor-
mance, adding further neuroimaging and molecular variables (e.g. WM
microstructure, neurotransmitter function or network connectivity)
might also contribute to a more complete picture (Hedden and
Growdon, 2015).
Nonetheless, in summary, our study suggests for the first time that
GM brain volume, corrected for brain atrophy, predicts EF in the el-
derly. Thus, atrophy-corrected global GM volume appears to be a pro-
mising quantitative brain reserve marker. In addition, several prior
studies reported an association of global and prefrontal cortical volume
with executive function in the elderly population (Elderkin-Thompson
et al., 2008; Cardenas et al., 2011; Zhang et al., 2011; Dong et al.,
2015). Our findings strengthen the view that global GM volume is
stronger associated with EF than lobar GM volumes.
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